Evidence map›Paper›PMID 19152136›Full record

Trial reportJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.

Arnold F Jacobson, John Lombard, Gopa Banerjee, Paolo G Camici

Registry-linked trialAbstract readClinical Trial, Phase III
PubMed Publisher
In one paragraph

Trial report in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03227393 (The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG), which is not on this map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03227393 nawithdrawnnot on this map

The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG

TypeinterventionalSponsorUniversity of CincinnatiRan2017 to 2017Enrolled0ConditionsHeart Failure, SystolicArmsYoga training
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. The prognostic value ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Pooled it
  2. Prognostic usefulness of planarJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Trial
  3. Trial
  4. Trial
  5. Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2012
    Trial
  6. Myocardial Sympathetic Innervation Imaging.Journal of nuclear medicine technology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. CardiacJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  11. How do we establish cardiac sympathetic nervous system imaging withJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  12. Neuro-cardiac imaging has a proven value in patient management: Con.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Article
  13. Assessment ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Article
  14. Ventricular arrhythmias and autonomic nervous system: evolving role of radionuclide imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Article
  15. Review
  16. It's not all in the numbers.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  17. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  18. Article
  19. Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Article
  20. Cardiac sympathetic imaging in the diagnosis of cardiac autonomic neuropathy in pre-diabetes.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Arnold F JacobsonGE Healthcare, 101 Carnegie Center, Princeton, NJ 08540, USA. arnold.jacobson@ge.com
John Lombard
Gopa Banerjee
Paolo G Camici
General Electric (Spain) · ESNIHR Imperial Biomedical Research Centre · GB

Funding

Medical Research Council MC_U120084164
6 · The paper itself

Abstract

backgroundADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) consists of two identical prospective open-label, multicenter, phase 3 studies (MBG311 and MBG312) evaluating the prognostic usefulness of (123)I-mIBG scintigraphy for identifying subjects with heart failure who will experience a major adverse cardiac event.

methodsSubjects with NYHA class II and III heart failure and left ventricular ejection fraction < or = 35% were eligible for the trials. Subjects underwent planar and SPECT (123)I-mIBG myocardial imaging, as well as echocardiography and gated SPECT (99m)Tc-tetrofosmin myocardial perfusion imaging. Subjects are then monitored on a regular basis for 2 years. Time to first occurrence of one of the following--NYHA class progression; potentially life-threatening arrhythmic event (including ICD discharge); or cardiac death, as verified by an independent adjudication panel---will be analyzed in comparison to quantitative parameters derived from (123)I-mIBG imaging. The primary efficacy analysis will employ the heart/mediastinum ratio on 4-hour delayed planar imaging, while secondary efficacy analyses will examine quantitative results from both planar and SPECT (123)I-mIBG images, as well as from (99m)Tc-tetrofosmin SPECT and echocardiography.

conclusionThe results of the ADMIRE-HF trials will provide prospective validation of the potential role of (123)I-mIBG scintigraphy in assessing prognosis and developing management strategies for patients with heart failure.

Indexed as

3-IodobenzylguanidineComorbidityEpidemiologic Research DesignFemaleHeart FailureHumansIncidenceInternationalityMaleRadiopharmaceuticalsRisk AssessmentRisk FactorsSurvival AnalysisSurvival RateTomography, Emission-Computed, Single-PhotonVentricular Dysfunction, Left3-IodobenzylguanidineRadiopharmaceuticals

Identifiers

PMID19152136
OpenAlexW2020697799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.